| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/02/1998 | WO1998028001A1 Treatment of autoimmune diseases, including aids |
| 07/02/1998 | WO1998027998A1 Remedies for cerebral ischemic diseases |
| 07/02/1998 | WO1998027997A1 A method for diagnosis and treatment of inflammatory bowel diseases including crohn's disease and chronic ulcerative colitis |
| 07/02/1998 | WO1998027996A1 A method of treatment and prophylaxis |
| 07/02/1998 | WO1998027995A1 Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells |
| 07/02/1998 | WO1998027994A1 Proteins and compositions for modulating mitosis |
| 07/02/1998 | WO1998027993A1 Protein crystals, their preparation and use |
| 07/02/1998 | WO1998027992A1 Antitumor active substances |
| 07/02/1998 | WO1998027980A2 Method of producing a sustained-release preparation |
| 07/02/1998 | WO1998027963A2 Gel composition and methods |
| 07/02/1998 | WO1998027962A2 Injectable depot gel composition and method of preparing the composition |
| 07/02/1998 | WO1998027932A2 Cerebellum and embryo specific protein |
| 07/02/1998 | WO1998027813A1 Methods for treating insulin resistance and identifying patients at risk for the disease |
| 07/02/1998 | WO1998027805A1 Antimicrobial proteins |
| 07/02/1998 | DE19700535C1 Use of polypeptide for treating liver diseases |
| 07/02/1998 | CA2591581A1 Gel composition and methods |
| 07/02/1998 | CA2276149A1 Methods for treating insulin resistance and identifying patients at risk for the disease |
| 07/02/1998 | CA2276090A1 Recombinant n-smases and nucleic acids encoding same |
| 07/02/1998 | CA2275708A1 Diagnosis and treatment of pathological pregnancies |
| 07/02/1998 | CA2275692A1 Treatment of autoimmune diseases |
| 07/02/1998 | CA2275540A1 Cerebellum and embryo specific protein |
| 07/02/1998 | CA2275483A1 Polysaccharide-peptide derivatives |
| 07/02/1998 | CA2275446A1 Protein crystals, their preparation and use |
| 07/02/1998 | CA2275436A1 Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells |
| 07/02/1998 | CA2275422A1 Method of producing a sustained-release preparation |
| 07/02/1998 | CA2275183A1 Ob fusion protein compositions and methods |
| 07/02/1998 | CA2275180A1 A variant human alpha-7 acetylcholine receptor subunit, and methods of production and use thereof |
| 07/02/1998 | CA2275138A1 Mammalian cytokine related to il10 |
| 07/02/1998 | CA2274899A1 New use of dipeptide derivatives |
| 07/02/1998 | CA2274799A1 Anti-obesity proteins |
| 07/02/1998 | CA2274734A1 Proteins and compositions for modulating mitosis |
| 07/02/1998 | CA2274730A1 Antimicrobial proteins |
| 07/02/1998 | CA2274675A1 Vegf-b/receptor complex and uses thereof |
| 07/02/1998 | CA2274586A1 Methods for detecting and inhibiting the rna component of telomerase |
| 07/02/1998 | CA2272855A1 Method of diagnosis and therapy of hodgkin's lymphomas |
| 07/02/1998 | CA2272305A1 Cycloalkyl, lactam, lactone and related compounds as .beta.-amyloid peptide release inhibitors |
| 07/02/1998 | CA2271715A1 Peptide antagonists of dp transcription factors |
| 07/02/1998 | CA2246787A1 Novel compounds |
| 07/02/1998 | CA2219265A1 Human cardiac/brain tolloid-like protein |
| 07/01/1998 | EP0851030A1 PROTEIN SPECIFIC TO HUMAN Th2, GENE (B19) ENCODING THE SAME, AND TRANSFORMANT, RECOMBINANT VECTOR AND MONOCLONAL ANTIBODY RELATING THERETO |
| 07/01/1998 | EP0850952A1 Interleukin-18-receptor proteins |
| 07/01/1998 | EP0850951A1 Novel feline cytokine protein |
| 07/01/1998 | EP0850950A1 Peptide derivatives |
| 07/01/1998 | EP0850924A1 Aromatic diselenides and selenosulphides for use as antioxidant agents |
| 07/01/1998 | EP0850648A2 Combination of thrombolytically active proteins and anticoagulants and uses thereof |
| 07/01/1998 | EP0850319A1 Method for modulating cell apoptosis |
| 07/01/1998 | EP0850313A2 Improved aav vectors for gene therapy |
| 07/01/1998 | EP0850310A1 Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 07/01/1998 | EP0850308A2 Hcv ns3 protein fragments having helicase activity and improved solubility |
| 07/01/1998 | EP0850301A2 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 07/01/1998 | EP0850252A1 Mutant plasminogen activator-inhibitor type 1 (pai-1) and uses thereof |
| 07/01/1998 | EP0850251A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 07/01/1998 | EP0850250A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
| 07/01/1998 | EP0850243A2 Peptide and o-glycan inhibitors of selectin mediated inflammation |
| 07/01/1998 | EP0850240A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 07/01/1998 | EP0850221A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 07/01/1998 | EP0850071A1 Gene therapy for effector cell regulation |
| 07/01/1998 | EP0850067A1 Method for treating cancers using 6- 3- 1-adamantyl]-4-hydroxyphenyl] |
| 07/01/1998 | EP0850053A1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 07/01/1998 | EP0850047A1 Therapeutic lipidic vesicles: methods of use and compositions |
| 07/01/1998 | EP0817792A4 Compositions for the diagnosis, prevention, and treatment of tumor progression |
| 07/01/1998 | EP0721352A4 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 07/01/1998 | EP0695308B1 Novel heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same |
| 07/01/1998 | EP0665755B1 Preparation of pharmaceutical compositions containing a calcitonin |
| 07/01/1998 | EP0654041B1 Peptidyl 4-amino-2,2-difluoro-3-oxo-1,6-hexanedioic acid derivatives as antiinflammatory agents |
| 07/01/1998 | EP0646127B1 Polypeptide bombesin antagonists |
| 07/01/1998 | EP0644896A4 PEPTIDES REPRESENTING ANTIGENIC EPITOPES OF IgE PRESENT ON B CELL BUT NOT BASOPHIL SURFACE. |
| 07/01/1998 | EP0640095B1 Process for making vancomycin |
| 07/01/1998 | EP0631584A4 Cancer diagnosis and therapy. |
| 07/01/1998 | EP0578728B1 PLATELET AGGREGATION INHIBITORS HAVING HIGH SPECIFICITY FOR GP IIbIIIa |
| 07/01/1998 | EP0546124B1 Multidomain hematopoiesis stimulators |
| 07/01/1998 | CN1186518A Human vascular endothelial growth factor 2 |
| 07/01/1998 | CN1186517A Altered polypeptides with increased half-life |
| 07/01/1998 | CN1186515A 转化生长因子αHI Transforming growth factor αHI |
| 07/01/1998 | CN1186514A Process for controlling sialylation of protein produced by mammalian cell culture |
| 07/01/1998 | CN1186501A Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
| 07/01/1998 | CN1186499A Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 07/01/1998 | CN1186495A Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 07/01/1998 | CN1186441A 脑水肿抑制剂 Brain edema inhibitors |
| 07/01/1998 | CN1186439A Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 07/01/1998 | CN1186438A Methods and compositions for healing and repair of connective tissue attachment |
| 07/01/1998 | CN1186432A Use of pyrrolidine derivatives for treating alcoholism |
| 07/01/1998 | CN1186431A Compositions and methods using nitroxides in combination with biocompatible macromolecules |
| 07/01/1998 | CN1186427A Osmotic device with delayed activation of drug delivery and complete drug release |
| 07/01/1998 | CN1186413A Moisture bacteriocin disinfectant wipes and methods of using the same |
| 07/01/1998 | CN1185975A Medicinal liquid for acne |
| 07/01/1998 | CN1185974A Human calcium degrading gene concerned peptide fatty composite and preparation thereof |
| 07/01/1998 | CN1038939C Preparation of peptide compounds |
| 07/01/1998 | CN1038931C Preparation of medicinal compositions useful as anta-gonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels |
| 06/30/1998 | US5773647 Using a aromatic compound containing amide and carboxy groups |
| 06/30/1998 | US5773602 DNA fragments obtained from a novel human immunodeficiency virus designated LAVMAL |
| 06/30/1998 | US5773601 Prevention of gene expression |
| 06/30/1998 | US5773586 Conjugates comprising truncated keratinocyte growth factor (KGF) having increased biological activity and a toxin |
| 06/30/1998 | US5773583 Methods and materials relating to the functional domains of DNA binding proteins |
| 06/30/1998 | US5773582 Tumor necrosis factor muteins |
| 06/30/1998 | US5773581 Acid stable substance dervived from naturally occuring granulocyte colony stimulating factor |
| 06/30/1998 | US5773580 Human protein kinase c inhibitor homolog |
| 06/30/1998 | US5773579 Comprising a membrane ion and a phosphorylation site; exhibits carbonic anhydrase activity |
| 06/30/1998 | US5773578 Polypeptides and proteins |
| 06/30/1998 | US5773577 Products comprising substrates capable of enzymatic cross-linking |